IL6 and myeloid sarcoma: A2BR stimulates the production of IL-6 in peripheral immune cells and plays pathogenic roles in MS/EAE by enhancing Th17 differentiation (Wei et al., 2013; Merighi et al., 2017) and functional polarization of microglial cells (Koscso et al., 2012; Franco et al., 2021).